Role of Clinical Pharmacists in Intensive Care Units

  title={Role of Clinical Pharmacists in Intensive Care Units},
  author={Enrique Arredondo and George Udeani and Michael A. Horseman and Trager D Hintze and Salim Surani},
The cost of health care has been rising in the United States and globally and will continue to increase. Intensive care unit (ICU) care carries a significant portion of the cost for the hospitals. The Institute of Medicine and subsequent studies have suggested that medication errors account for significant morbidity, mortality, and cost, frequently encountered in the ICU. Over the past three decades, clinical pharmacists have emerged from dispensing medication to getting involved in direct… 
2 Citations

Figures from this paper

Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Possible drug interactions, their underlying pharmacological mechanisms, and possible clinical signs that healthcare providers in COVID-19 clinics may need to acknowledge as adverse drug reactions due to drug-drug interactions are discussed.
Unraveling the Worth of a Clinical Pharmacist
  • B. Krishna
  • Medicine
    Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine
  • 2021
How to cite this article Krishna B. Srinivasan's Unraveling the Worth of a Clinical Pharmacist: The Case for and against a Pharmacist’s Pharmacy Licence is explained.


The impact of critical care pharmacists on enhancing patient outcomes
The purpose of this article is to review the literature pertaining to pharmacists' contributions within a multidisciplinary intensivist-led intensive care unit (ICU) team.
Intensive care unit antimicrobial resistance and the role of the pharmacist
This review will address the many issues that surround the appropriate use of antibiotics and what role the pharmacist can play in ensuring the optimal use of infection control measures in the ICU and hospital.
The Critical Care Pharmacist: An Essential Intensive Care Practitioner
Clinical pharmacy services in the critical care setting have expanded dramatically and include assisting physicians in pharmacotherapy decision making, providing pharmacokinetic consultations,
Characterizing Critical Care Pharmacy Services Across the United States
ICU pharmacists have diverse and versatile responsibilities and provide several key clinical and nonclinical services and Initiatives to increase the availability of services are warranted.
Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
Critical Care Pharmacy Services in United States Hospitals
Clinical pharmacists are directly involved as caregivers in nearly two-thirds of ICUs in the US, and although they provide a range of clinical and administrative services, involvement in educational and scholarly activities is variable.
Position Paper on Critical Care Pharmacy Services
The goals were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and manager, and to recommend fundamental, desirable, and optimal pharmacy services and personnel requirements for the provision of pharmaceutical care to critically ill patients.
Reducing medication errors in critical care: a multimodal approach
Challenges related to drug formulation are specific to the various routes of medication administration, though errors associated with medication appearance and labeling occur among all drug formulations and routes of administration.
Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients.
A 1999 Institute of Medicine report received national attention by highlighting system vulnerabilities within health care and indicating that medication errors are a leading cause of morbidity and
Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study
Pharmacist dosing adjustment for patients receiving CRRT was well accepted by physicians, and was related with lower adverse drug event rates and ICU cost savings.